Fintel on MSN2d
JMP Securities Initiates Coverage of KalVista Pharmaceuticals (KALV) with Market Outperform Recommendation
Fintel reports that on January 31, 2025, JMP Securities initiated coverage of KalVista Pharmaceuticals (NasdaqGM:KALV) with a Market Outperform recommendation. Analyst Price Forecast Suggests 219.11% ...
Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...
JMP Securities Sticks to Their Hold Rating for Atlassian (TEAM)
In a report released today, Patrick Walravens from JMP Securities maintained a Hold rating on Atlassian (TEAM – Research Report). The company’s ...
JMP Securities Sticks to Its Hold Rating for LegalZoom (LZ)
In a report released today, Andrew Boone from JMP Securities maintained a Hold rating on LegalZoom (LZ – Research Report). The company’s shares ...
JMP Securities Raises CyberArk Software Ltd. (CYBR) Price Target to $390 on Strong Identity Security Outlook
AI is evolving rapidly with recent breakthroughs making it more accessible and efficient than ever. Smaller, cost-effective ...
Why Cloudflare Stock Soared Today
The web services and cybersecurity specialist's share price ended the day's trading up 10.7% amid the backdrop of a 0.8% gain ...
Cloudflare, CyberArk see price targets raised at JMP ahead of earnings
JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...